Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tempus AI
TEM
5
Warner Bros Discovery
WBD
US Stock MarketDetailed Quotes
Takeda Pharmaceutical (TAK)
- 16.095
- -0.235-1.44%
Trading Jan 16 11:01 ET
51.21BMarket Cap247.62P/E (TTM)
16.115High16.050Low632.27KVolume16.070Open16.330Prev Close10.17MTurnover0.02%Turnover Ratio75.92P/E (Static)3.18BShares16.48052wk High1.14P/B49.60BFloat Cap12.23652wk Low0.67Dividend TTM3.08BShs Float19.024Historical High4.14%Div Yield TTM0.40%Range %10.810Historical Low16.081Avg Price1Lot Size
Takeda Pharmaceutical (TAK) Key Financial Indicators
TAK Earnings per Share (EPS)
According to the latest financial report of Takeda Pharmaceutical, the latest earnings per share (TTM) for the company is -3.92. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
TAK Free Cash Flow (FCF)
Interested in knowing about Takeda Pharmaceutical's free cash flow? The latest report shows it as 325.40B. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
TAK Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Takeda Pharmaceutical shows that the company's current ratio is 1.36, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
TAK Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Takeda Pharmaceutical, the quick ratio is 0.67, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
TAK Return on Equity (ROE)
Want to learn more about the financial health of Takeda Pharmaceutical? The latest ROE figure is -0.17%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
TAK Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Takeda Pharmaceutical, the total asset return on investment (ROA) is -0.08%.
Currency: JPY
Quarterly
Loading...
TAK Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Takeda Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 65.85%.
Currency: JPY
Quarterly
Loading...
TAK Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Takeda Pharmaceutical, the net profit margin is -1.05%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...
Market Insights
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec
今日熱門
Dec 11, 2025 03:27
December FOMC Interest Rate Meeting
牛牛課堂
Dec 19, 2025 12:28
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?